Research Article
Oxidative Stress: Dual Pathway Induction in Cardiorenal Syndrome Type 1 Pathogenesis
Table 1
Baseline characteristics of CRS Type 1 and AHF patients and clinical parameters.
| | | AHF | CRS Type 1 | value |
| | Age, years | 80.0 ± 8.0 | 76.0 ± 13.0 | NS | | Weight, Kg | 75 (64–88) | 77 (67–85) | NS | | Diabetes | 42% | 64% | NS | | Hypertension | 92% | 91% | NS | | Peripheral vascular disease | 42% | 45% | NS | | Cardiovascular disease | 17% | 18% | NS | | Obesity | 25% | 27% | NS | | Dyslipidemia | 42% | 45% | NS | | Creatinine, mg/dL | 0.98 (0.87–1.15) | 0.96 (0.88–1.02) | NS | | eGFR, mL/min/1.73 m2 | 67 (53–82) | 62 (55–75) | NS | | Mean arterial pressure (MAP), mm/Hg | 103.3 (93.3–120.8) | 100 (89.2–115.8) | NS | | Ejection fraction | 35% (24.0–48.0) | 35% (25.0–51.0) | NS | | BNP, pg/mL | 632 (398.3–946) | 695 (408.5–1837) | NS | | Troponin I, ng/mL | 0.07 (0.04–0.27) | 0.07 (0.04–0.26) | NS | | Hemoglobin, g/dL | 11.1 (13.6–14.25) | 11.4 (9.7–13) | NS | | Albumin, g/L | 4.01 (4.18–4.4) | 4.3 (3.96–4.4) | NS | | AST, U/L | 22 (13.5–30.5) | 21 (18.8–25.3) | NS | | ALT, U/L | 16 (13–30.5) | 19 (17.3–25) | NS | | LDH, U/L | 367 (340–462) | 435 (382–621) | NS | | CPK, U/L | 88 (48.5–115) | 66.5 (38.5–83.5) | NS |
|
|
Values denote means ± SD or medians (IQR) unless specified otherwise.
|
